CLINICAL AND PROGNOSTIC PROFILE OF PATIENTS WITH DILATED CARDIOMYOPATHY CAUSED BY MUTATIONS IN MYBPC3 GENE

Bibliographic Details
Main Authors:	Alexandra Sousa, Paulo Canedo, Brenda Moura, Luís Lopes, Olga Azevedo, Sandra Amorim, Francisco Rocha Gonçalves, José Carlos Machado, José Silva-Cardoso, Elisabete Martins
Format:	Article
Language:	English
Published:	Centro Hospitalar do Porto 2016-12-01
Series:	Nascer e Crescer
Online Access:	http://revistas.rcaap.pt/nascercrescer/article/view/10526

Similar Items

Oxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation
by: Thomas L. Lynch, et al.
Published: (2015-01-01)

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the <it>MYBPC3 </it>gene
by: Lehrke Stephanie, et al.
Published: (2008-10-01)

Molecular characterization of Portuguese patients with dilated cardiomyopathy
by: Alexandra Sousa, et al.
Published: (2019-02-01)

Molecular characterization of Portuguese patients with dilated cardiomyopathy
by: Alexandra Sousa, et al.
Published: (2019-02-01)

ARRHYTHMIC RISK AND GENETIC VARIATIONS IN DILATED CARDIOMYOPATHY PATIENTS
by: Elisabete Martins, et al.
Published: (2016-12-01)

Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
by: Elisabete Martins, et al.
Published: (2019-06-01)

Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
by: Elisabete Martins, et al.
Published: (2019-06-01)

Genetic Variants Are Not Rare in ICD Candidates with Dilated Cardiomyopathy: Time for Next-Generation Sequencing?
by: Alexandra Sousa, et al.
Published: (2019-01-01)

Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy
by: Sandra Amorim, et al.
Published: (2016-05-01)

Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy
by: Sandra Amorim, et al.
Published: (2016-05-01)

Familial hypertrophic cardiomyopathy: A case with a new mutation in the MYBPC3 gene
by: Olgu Hallioglu Kilinc, et al.
Published: (2017-07-01)

Autosomal recessive transmission of MYBPC3 mutation results in malignant phenotype of hypertrophic cardiomyopathy.
by: Yilu Wang, et al.
Published: (2013-01-01)

Investigation of Mutations in Exons 15 and 18 of MYBPC3 Gene in Hypertrophic Cardiomyopathy Patients
by: Behnaz Sadat Abedi, et al.
Published: (2015-08-01)

The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy.
by: Benedicte Jørgenrud, et al.
Published: (2015-01-01)

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
by: Javier Diez, et al.
Published: (2020-06-01)

MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy.
by: James W McNamara, et al.
Published: (2017-01-01)

MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy
by: McNamara, James W., et al.
Published: (2017)

EXAMINING THE EFFICACY OF MYBPC BASED THERAPIES IN MOUSE MODELS OF CARDIOMYOPATHIES
by: Li, Jiayang
Published: (2019)

Combined PTPN11 and MYBPC3 Gene Mutations in an Adult Patient with Noonan Syndrome and Hypertrophic Cardiomyopathy
by: Martina Caiazza, et al.
Published: (2020-08-01)

Mixed Hypertrophic and Dilated Phenotype of Cardiomyopathy in a Patient With Homozygous In-Frame Deletion in the MyBPC3 Gene Treated as Myocarditis for a Long Time
by: Olga Blagova, et al.
Published: (2020-09-01)

The Mutations Associated with Dilated Cardiomyopathy
by: Ruti Parvari, et al.
Published: (2012-01-01)

Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model
by: Ewa Dziewięcka, et al.
Published: (2020-10-01)

Congenital Complete Atrioventricular Block and Dilated Cardiomyopathy: New Light for an Old Disease
by: Mariana Paiva, et al.
Published: (2012-01-01)

The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling
by: Sandra Amorim, et al.
Published: (2017-10-01)

The role of biomarkers in dilated cardiomyopathy: Assessment of clinical severity and reverse remodeling
by: Sandra Amorim, et al.
Published: (2017-10-01)

Erratum to “Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy” (Rev. Port. Cardiol. 2016;35(5):253-260)
by: Sandra Amorim, et al.
Published: (2017-03-01)

Erratum to “Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy” (Rev. Port. Cardiol. 2016;35(5):253-260)
by: Sandra Amorim, et al.
Published: (2017-03-01)

Idiopathic dilated cardiomyopathy in children: Prognostic indicators
by: Mehmet Emre Arı, et al.
Published: (2019-04-01)

Prognostic significance of midwall fibrosis in dilated cardiomyopathy
by: Gulati Ankur, et al.
Published: (2012-02-01)

Severe apical hypertrophic cardiomyopathy with Ser 236 Gly mutation in MYBPC3: A three-year follow-up investigation
by: XueJiang Cen, et al.
Published: (2017-09-01)

Phenotypic Diversity of Cardiomyopathy Caused by an <i>MYBPC3</i> Frameshift Mutation in a Korean Family: A Case Report
by: Joonhong Park, et al.
Published: (2021-03-01)

OBSCN Mutations Associated with Dilated Cardiomyopathy and Haploinsufficiency.
by: Steven Marston, et al.
Published: (2015-01-01)

Neonatal dilated cardiomyopathy
by: Paulo Soares, et al.
Published: (2017-03-01)

Neonatal dilated cardiomyopathy
by: Paulo Soares, et al.
Published: (2017-03-01)

Prognostic value of free triiodothyronine in patients with dilated cardiomyopathy
by: Hong-Yan Zhao, et al.
Published: (2020-09-01)

Mutation in δ-Sg Gene in Familial Dilated Cardiomyopathy
by: Marzieh Asadi, et al.
Published: (2017-01-01)

FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy
by: Rene L. Begay, BS, et al.
Published: (2016-08-01)

Prognostic value of left atrial volume in patients with dilated cardiomyopathy
by: Filipa Ferreira, et al.
Published: (2013-11-01)

Repair of Mybpc3 mRNA by 5′-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy
by: Giulia Mearini, et al.
Published: (2013-01-01)

Pathogenic Intronic Splice-Affecting Variants in <i>MYBPC3</i> in Three Patients with Hypertrophic Cardiomyopathy
by: Katherine A. Wood, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_nrtsbfap7ntr5mc5sg5dv7mvds